Brachytherapy after lumpectomy may be an effective alternative to conventional treatments in women with early-stage breast cancer with breast implants.
Brachytherapy after lumpectomy may be an effective alternative to conventional treatments in women with early-stage breast cancer who have undergone breast augmentation, according to research presented at the annual meeting of the Radiological Society of North America held Nov. 30 to Dec. 5 in Chicago.
Robert R. Kuske Jr., MD, of the University of Arizona Health Sciences Center in Scottsdale, and colleagues studied 65 women who received two daily treatments of high-dose rate Iridium-192 brachytherapy for 5 days.
After a median follow-up of 16 months, the researchers found that none of the women experienced tumor recurrence or capsular contracture, a common and painful side effect in women with breast implants who receive whole-breast radiation therapy after lumpectomy.
Kuske is a consultant for Nucletron and for Cianna Medical.
More information is available at http://rsna2008.rsna.org/.
Study: Plant-based diets lower hypertensive disorders of pregnancy risk
March 28th 2024A recent study suggests that adherence to plant-based diets significantly decreases the risk of developing hypertensive disorders of pregnancy, shedding light on dietary interventions for maternal health.
Read More
How genetic variables impact oral contraceptive use and VTE risk
March 27th 2024A comprehensive study delved into the interplay of polygenic and hereditary factors in venous thromboembolism risk among oral contraceptive users, shedding light on potential genetic markers for refined risk assessment and counseling.
Read More